MassMutual Private Wealth & Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $906K | Sell |
7,173
-26
| -0.4% | -$3.43K | 0.02% | 267 |
|
|
2026
Q1 | $1M | Sell |
7,199
-485
| -6% | -$67.9K | 0.03% | 240 |
|
|
2025
Q4 | $943K | Sell |
7,684
-98
| -1% | -$11.9K | 0.02% | 249 |
|
|
2025
Q3 | $864K | Buy |
7,782
+59
| +0.8% | +$6.71K | 0.02% | 261 |
|
|
2025
Q2 | $856K | Buy |
7,723
+117
| +2% | +$12.5K | 0.02% | 261 |
|
|
2025
Q1 | $852K | Buy |
7,606
+1,575
| +26% | +$163K | 0.02% | 259 |
|
|
2024
Q4 | $557K | Buy |
6,031
+1,094
| +22% | +$98.5K | 0.02% | 305 |
|
|
2024
Q3 | $414K | Buy |
4,937
+450
| +10% | +$34.3K | 0.01% | 322 |
|
|
2024
Q2 | $308K | Buy |
4,487
+1,887
| +73% | +$126K | 0.01% | 349 |
|
|
2024
Q1 | $190K | Sell |
2,600
-117
| -4% | -$9K | 0.01% | 385 |
|
|
2023
Q4 | $220K | Buy |
2,717
+383
| +16% | +$29.8K | 0.01% | 363 |
|
|
2023
Q3 | $175K | Buy |
2,334
+234
| +11% | +$18K | 0.01% | 384 |
|
|
2023
Q2 | $162K | Buy |
2,100
+367
| +21% | +$29.3K | 0.01% | 376 |
|
|
2023
Q1 | $144K | Buy |
1,733
+139
| +9% | +$11.5K | 0.01% | 380 |
|
|
2022
Q4 | $137K | Buy |
1,594
+25
| +2% | +$1.98K | 0.01% | 380 |
|
|
2022
Q3 | $97K | Buy |
1,569
+559
| +55% | +$35.3K | ﹤0.01% | 392 |
|
|
2022
Q2 | $62K | Buy |
1,010
+154
| +18% | +$9.54K | ﹤0.01% | 439 |
|
|
2022
Q1 | $51K | Sell |
856
-614
| -42% | -$39.2K | ﹤0.01% | 467 |
|
|
2021
Q4 | $107K | Buy |
1,470
+169
| +13% | +$11.6K | ﹤0.01% | 402 |
|
|
2021
Q3 | $91K | Buy |
1,301
+907
| +230% | +$63.7K | ﹤0.01% | 405 |
|
|
2021
Q2 | $27K | Buy |
394
+229
| +139% | +$15.3K | ﹤0.01% | 537 |
|
|
2021
Q1 | $11K | Sell |
165
-341
| -67% | -$22K | ﹤0.01% | 589 |
|
|
2020
Q4 | $29K | Sell |
506
-26,750
| -98% | -$1.61M | ﹤0.01% | 491 |
|
|
2020
Q3 | $1.72M | Buy |
27,256
+653
| +2% | +$45.3K | 0.1% | 161 |
|
|
2020
Q2 | $2.05M | Sell |
26,603
-6,689
| -20% | -$513K | 0.13% | 156 |
|
|
2020
Q1 | $2.49M | Buy |
33,292
+861
| +3% | +$59.5K | 0.2% | 129 |
|
|
2019
Q4 | $2.11M | Sell |
32,431
-1,056
| -3% | -$68.8K | 0.13% | 163 |
|
|
2019
Q3 | $2.12M | Buy |
33,487
+3,125
| +10% | +$204K | 0.14% | 154 |
|
|
2019
Q2 | $2.05M | Buy |
30,362
+3,875
| +15% | +$255K | 0.14% | 153 |
|
|
2019
Q1 | $1.72M | Buy |
26,487
+5,187
| +24% | +$345K | 0.12% | 159 |
|
|
2018
Q4 | $1.33M | Sell |
21,300
-340
| -2% | -$23.8K | 0.11% | 157 |
|
|
2018
Q3 | $1.67M | Buy |
21,640
+448
| +2% | +$33.8K | 0.12% | 153 |
|
|
2018
Q2 | $1.5M | Sell |
21,192
-635
| -3% | -$44.8K | 0.12% | 154 |
|
|
2018
Q1 | $1.65M | Buy |
21,827
+172
| +0.8% | +$13.7K | 0.14% | 146 |
|
|
2017
Q4 | $1.55M | Sell |
21,655
-3,303
| -13% | -$251K | 0.13% | 147 |
|
|
2017
Q3 | $2.02M | Sell |
24,958
-357
| -1% | -$27.3K | 0.17% | 138 |
|
|
2017
Q2 | $1.79M | Sell |
25,315
-2,113
| -8% | -$141K | 0.16% | 145 |
|
|
2017
Q1 | $1.86M | Sell |
27,428
-17,804
| -39% | -$1.25M | 0.18% | 144 |
|
|
2016
Q4 | $3.24M | Buy |
+45,232
| New | +$3.36M | 0.4% | 77 |
|
|
2016
Q2 | $4.89M | Sell |
58,591
-5,187
| -8% | -$460K | 0.62% | 36 |
|
|
2016
Q1 | $5.86M | Buy |
63,778
+3,606
| +6% | +$325K | 0.79% | 27 |
|
|
2015
Q4 | $6.09M | Buy |
60,172
+3,674
| +7% | +$382K | 0.87% | 25 |
|
|
2015
Q3 | $6.01M | Sell |
56,498
-1,032
| -2% | -$115K | 1.27% | 15 |
|
|
2015
Q2 | $4.77M | Sell |
57,530
-2,980
| -5% | -$326K | 1.07% | 21 |
|
|
2015
Q1 | $5.94M | Buy |
60,510
+46,780
| +341% | +$4.75M | 0.98% | 21 |
|
|
2014
Q4 | $1.29M | Sell |
13,730
-42,768
| -76% | -$4.42M | 0.42% | 73 |
|
|
2014
Q3 | $6.01M | Buy |
56,498
+43,004
| +319% | +$4.21M | 1.2% | 17 |
|
|
2014
Q2 | $1.12M | Buy |
13,494
+1,981
| +17% | +$154K | 0.44% | 58 |
|
|
2014
Q1 | $816K | Buy |
11,513
+6,761
| +142% | +$530K | 0.48% | 62 |
|
|
2013
Q4 | $357K | Buy |
+4,752
| New | +$331K | 0.33% | 64 |
|
Other funds holding GILD
MassMutual Private Wealth & Trust's GILD Position: Q2 2026 in Review
MassMutual Private Wealth & Trust reduced its Gilead Sciences (GILD) stake by 0.36% in Q2 2026, selling an estimated $3.43K and leaving 7,173 shares worth $906K. The position accounts for 0.02% of the portfolio, ranked #267.
MassMutual Private Wealth & Trust first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $6.09M in Q4 2015. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- MassMutual Private Wealth & Trust held 7,173 shares of Gilead Sciences worth $906K as of Q2 2026.
- MassMutual Private Wealth & Trust sold 26 Gilead Sciences shares in Q2 2026, an estimated $3.43K.
- Gilead Sciences made up 0.02% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #267 holding.
- MassMutual Private Wealth & Trust first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
- MassMutual Private Wealth & Trust's Gilead Sciences position peaked at $6.09M in Q4 2015.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.